Short Interest in Healios K.K. (OTCMKTS:HLOSF) Drops By 92.4%

Healios K.K. (OTCMKTS:HLOSF) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 4,800 shares, a decrease of 92.4% from the October 31st total of 62,900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Healios K.K. Price Performance

Shares of HLOSF stock remained flat at 1.20 on Wednesday. The company has a 50 day moving average of 1.55 and a two-hundred day moving average of 1.34. Healios K.K. has a 52 week low of 0.93 and a 52 week high of 1.73.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.